$2.33T
Total marketcap
$108.86B
Total volume
BTC 49.97%     ETH 15.43%
Dominance

Lipidor AB (publ) LIPI.ST Stock

0.25 SEK {{ price }} 3.781508% {{change_pct}}%
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
7.16M SEK
LOW - HIGH [24H]
0.22 - 0.27 SEK
VOLUME [24H]
259.21K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-0.52 SEK

Lipidor AB (publ) Price Chart

Lipidor AB (publ) LIPI.ST Financial and Trading Overview

Lipidor AB (publ) stock price 0.25 SEK
Previous Close 1.45 SEK
Open 1.46 SEK
Bid 1.6 SEK x N/A
Ask 1.6 SEK x N/A
Day's Range 1.46 - 1.68 SEK
52 Week Range 0.4 - 9.4 SEK
Volume 55.82K SEK
Avg. Volume 145.05K SEK
Market Cap 46.36M SEK
Beta (5Y Monthly) -0.014238
PE Ratio (TTM) N/A
EPS (TTM) -0.52 SEK
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

LIPI.ST Valuation Measures

Enterprise Value 29.32M SEK
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 167.98203
Price/Book (mrq) 18.181818
Enterprise Value/Revenue 106.247
Enterprise Value/EBITDA -0.905

Trading Information

Lipidor AB (publ) Stock Price History

Beta (5Y Monthly) -0.014238
52-Week Change -75.83%
S&P500 52-Week Change 20.43%
52 Week High 9.4 SEK
52 Week Low 0.4 SEK
50-Day Moving Average 0.7 SEK
200-Day Moving Average 2.45 SEK

LIPI.ST Share Statistics

Avg. Volume (3 month) 145.05K SEK
Avg. Daily Volume (10-Days) 496.11K SEK
Shares Outstanding 28.98M
Float 18.46M
Short Ratio N/A
% Held by Insiders 42.52%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -11843.84%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -76.067%
Return on Equity (ttm) -170.72%

Income Statement

Revenue (ttm) 276K SEK
Revenue Per Share (ttm) 0.01 SEK
Quarterly Revenue Growth (yoy) -66.70%
Gross Profit (ttm) -29730000 SEK
EBITDA -32409000 SEK
Net Income Avi to Common (ttm) -29864000 SEK
Diluted EPS (ttm) -0.9
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 8.2M SEK
Total Cash Per Share (mrq) 0.28 SEK
Total Debt (mrq) 0 SEK
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.973
Book Value Per Share (mrq) 0.088

Cash Flow Statement

Operating Cash Flow (ttm) -30399000 SEK
Levered Free Cash Flow (ttm) -18008000 SEK

Profile of Lipidor AB (publ)

Country Sweden
State N/A
City Danderyd
Address Svärdvägen 13
ZIP 182 33
Phone 46 7 25 07 03 69
Website https://lipidor.se
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees N/A

Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, acne vulgaris, bacterial skin infections, and atopic dermatitis. The company develops AKP-01, which is in Phase III for the treatment of psoriasis; and preclinical stage products, such as AKP-02 for psoriasis, AKP-03 for bacterial skin diseases, and AKP-07 for atopic dermatitis. It offers active pharmaceutical ingredients used in products for various therapeutic applications, such as anti-psoriasic, antimicrobial, anti-inflammatory, antifungal, local anesthetics, non-steroidal anti-inflammatory, anti-acne, wound healing, anti-eczema, and anti-migraine. The company also develops a range of spray products for animal skin care in dogs, cats, and horses; and consumer health care products for applications, including antibacterial, antiseptic, moisturizing emollient, disinfectant, and acne and wart treatment. It has a collaboration agreement with Cannassure Therapeutics Ltd. for the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. The company was incorporated in 2009 and is based in Danderyd, Sweden.

Q&A For Lipidor AB (publ) Stock

What is a current LIPI.ST stock price?

Lipidor AB (publ) LIPI.ST stock price today per share is 0.25 SEK.

How to purchase Lipidor AB (publ) stock?

You can buy LIPI.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Lipidor AB (publ)?

The stock symbol or ticker of Lipidor AB (publ) is LIPI.ST.

Which industry does the Lipidor AB (publ) company belong to?

The Lipidor AB (publ) industry is Drug Manufacturers-General.

How many shares does Lipidor AB (publ) have in circulation?

The max supply of Lipidor AB (publ) shares is 28.98M.

What is Lipidor AB (publ) Price to Earnings Ratio (PE Ratio)?

Lipidor AB (publ) PE Ratio is now.

What was Lipidor AB (publ) earnings per share over the trailing 12 months (TTM)?

Lipidor AB (publ) EPS is -0.52 SEK over the trailing 12 months.

Which sector does the Lipidor AB (publ) company belong to?

The Lipidor AB (publ) sector is Healthcare.

Lipidor AB (publ) LIPI.ST included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
First North Sweden EUR GI FNSEEURGI 1570.14 EUR 1716.38 USD
-0.77
First North Health Care GI FN20GI 917.04 EUR 1002.44 USD
-1.17
First North All-Share EUR FIRSTNORTHEUR 97.9 EUR 107.01 USD
-0.64
First North Sweden SEK PI FNSESEKPI 1843.91 SEK 179.99 USD
-0.28
First North Sweden EUR PI FNSEEURPI 1479.5 EUR 1617.29 USD
-0.77
First North Health Care PI FN20PI 912.9 EUR 997.92 USD
-1.17
First North All-Share SEK FIRSTNORTHSEK 123.34 SEK 12.04 USD
-0.14
First North All-Share DKK FIRSTNORTHDKK 97.96 DKK 14.36 USD
-0.62
First North Sweden SEK GI FNSESEKGI 1956.89 SEK 191.02 USD
-0.28